A Bit About Me
I'm Will Khan, a data scientist with a decade of experience in the field. My career began as a computational neuroscientist, where I applied cutting-edge machine learning techniques to identify biological markers in the brain, predicting the diagnosis of Alzheimer's disease. I furthered my research by exploring similar techniques to assess the likelihood of degenerative diseases in stroke survivors in Australia.
​
After an enriching research career, I sought to apply my technical expertise to real-world challenges, leading to my transition into professional services consulting. I've since worked across diverse industries, including retail, non-for-profit, finance, healthcare, and state government. This varied experience has deepened my understanding of the transformative power of analytics. Today, as an independent consultant, I focus on delivering specialised services that address core business problems and provide value, no matter the level of data maturity
Work Experience
Analytics Lead (Principal)
Notitia
October 2023 - May 2024
Data Scientist
PwC Australia
June 2021 - October 2023
Lead Data Scientist
Monash University
May 2020 - May 2021
Lead Data Scientist
Flory Institute of Neuroscience
September 2017 - May 2020
At Notitia, an analytics consultancy start-up, I served as the Analytics Lead, where I translated complex business problems into data-driven solutions. My work primarily involved collaborations with state government and primary health networks in Australia, with a strong focus on Microsoft Azure and Power BI reporting, and supply chain optimisation.
At PwC Australia, I served as a Data Scientist in the Analytics and AI consulting division, specialising in analytical solutions for blue-chip clients in the Retail and FMCG sectors. My expertise included supply chain optimization, inventory management, demand forecasting, and pricing and promotion analytics.
At Monash University, I worked with the iBRAIN group, applying advanced analytical techniques to identify disease markers in the human brain for rare degenerative disorders like Friedreich Ataxia and Huntington's disease.
At the Florey Institute, I developed innovative techniques for mapping post-stroke brain changes, aimed at enhancing patient care and improving outcomes.
